DE69637874D1 - C-C CHEMOKIN REZEPTOR 3: CKR-3 ODER Eos-L2 - Google Patents
C-C CHEMOKIN REZEPTOR 3: CKR-3 ODER Eos-L2Info
- Publication number
- DE69637874D1 DE69637874D1 DE69637874T DE69637874T DE69637874D1 DE 69637874 D1 DE69637874 D1 DE 69637874D1 DE 69637874 T DE69637874 T DE 69637874T DE 69637874 T DE69637874 T DE 69637874T DE 69637874 D1 DE69637874 D1 DE 69637874D1
- Authority
- DE
- Germany
- Prior art keywords
- ckr
- eos
- recombinant
- receptor
- polypeptides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/642—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the peptide or protein in the drug conjugate being a cytokine, e.g. IL2, chemokine, growth factors or interferons being the inactive part of the conjugate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- C07K14/7158—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for chemokines
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/375,199 US6806061B1 (en) | 1995-01-19 | 1995-01-19 | G protein-coupled receptor gene and methods of use therefor |
PCT/US1996/000608 WO1996022371A2 (en) | 1995-01-19 | 1996-01-19 | C-C CHEMOKINE RECEPTOR 3: CKP-3 OR Eos-L2 |
Publications (1)
Publication Number | Publication Date |
---|---|
DE69637874D1 true DE69637874D1 (de) | 2009-04-30 |
Family
ID=23479910
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69637874T Expired - Lifetime DE69637874D1 (de) | 1995-01-19 | 1996-01-19 | C-C CHEMOKIN REZEPTOR 3: CKR-3 ODER Eos-L2 |
Country Status (10)
Country | Link |
---|---|
US (1) | US6806061B1 (de) |
EP (1) | EP0828828B1 (de) |
JP (1) | JPH10512753A (de) |
KR (1) | KR19980701570A (de) |
AT (1) | ATE426024T1 (de) |
AU (1) | AU688206B2 (de) |
CA (1) | CA2207086A1 (de) |
DE (1) | DE69637874D1 (de) |
ES (1) | ES2324502T3 (de) |
WO (1) | WO1996022371A2 (de) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6537764B1 (en) | 1995-01-19 | 2003-03-25 | Children's Medical Center Corporation | Method of identifying inhibitors of C—C chemokine receptor 3 |
US6806061B1 (en) * | 1995-01-19 | 2004-10-19 | Children's Medical Center Corporation | G protein-coupled receptor gene and methods of use therefor |
US6025154A (en) | 1995-06-06 | 2000-02-15 | Human Genome Sciences, Inc. | Polynucleotides encoding human G-protein chemokine receptor HDGNR10 |
US6743594B1 (en) | 1995-06-06 | 2004-06-01 | Human Genome Sciences, Inc. | Methods of screening using human G-protein chemokine receptor HDGNR10 (CCR5) |
US6512103B1 (en) | 1995-12-08 | 2003-01-28 | Schering Corporation | Mammalian chemokine reagents |
US6265184B1 (en) | 1995-12-20 | 2001-07-24 | Icos Corporation | Polynucleotides encoding chemokine receptor 88C |
EP1012190A4 (de) * | 1996-04-26 | 2004-04-28 | Merck & Co Inc | Eotaxinrezeptor aus Eosinophilen |
US6271347B1 (en) | 1996-04-26 | 2001-08-07 | Merck & Co., Inc. | Eosinophil eotaxin receptor |
ATE360689T1 (de) * | 1996-09-10 | 2007-05-15 | Kocher Theodor Inst | Cxcr3 chemokine rezeptor, antikoerper, nukleinsaeure und deren verfahren zur anwendung |
WO1998032858A2 (en) * | 1997-01-23 | 1998-07-30 | Schering Corporation | Mammalian chemokines; receptors; reagents; uses |
US7067117B1 (en) | 1997-09-11 | 2006-06-27 | Cambridge University Technical Services, Ltd. | Compounds and methods to inhibit or augment an inflammatory response |
US6989435B2 (en) | 1997-09-11 | 2006-01-24 | Cambridge University Technical Services Ltd. | Compounds and methods to inhibit or augment an inflammatory response |
US6204024B1 (en) | 1997-09-12 | 2001-03-20 | Akzo Nobel N.V. | CCR5 RNA transcription based amplification assay |
US6110695A (en) * | 1997-12-02 | 2000-08-29 | The Regents Of The University Of California | Modulating the interaction of the chemokine, B Lymphocyte Hemoattractant, and its Receptor, BLR1 |
CA2235420A1 (en) | 1998-06-17 | 1999-12-17 | Paolo Renzi | Antisense oligonucleotides for treating or preventing atopic diseases and neoplastic cell proliferation |
US7238711B1 (en) | 1999-03-17 | 2007-07-03 | Cambridge University Technical Services Ltd. | Compounds and methods to inhibit or augment an inflammatory response |
US6664373B1 (en) | 1999-03-01 | 2003-12-16 | Millennium Pharmaceuticals, Inc. | TWIK-5 potassium channel polypeptides and uses therefor |
US6670149B1 (en) | 1999-03-01 | 2003-12-30 | Millennium Pharmaceuticals, Inc. | TWIK-5 potassium channel nucleic acids and uses therefor |
US6358697B2 (en) | 1999-04-21 | 2002-03-19 | Children's Hospital Medical Center | Intracellular pharmaceutical targeting |
GB0013345D0 (en) * | 2000-06-01 | 2000-07-26 | Glaxo Group Ltd | Modified receptor and assay |
US6692922B2 (en) | 2000-08-15 | 2004-02-17 | The Board Of Trustees Of The Leland Stanford Junior University | Method for identifying agents which modulate chemokine “MEC”-induced functions of CCR3 |
US7175988B2 (en) | 2001-02-09 | 2007-02-13 | Human Genome Sciences, Inc. | Human G-protein Chemokine Receptor (CCR5) HDGNR10 |
NZ531069A (en) * | 2001-08-10 | 2007-01-26 | Topigen Pharma Inc | Methods for modulating viral infection of cells by modulating a binding interaction between a CCR1, CCR2, CCR3, CCR4, CCR5 and/or CCR8 receptor and a surface protein of the virus |
US7393934B2 (en) | 2001-12-21 | 2008-07-01 | Human Genome Sciences, Inc. | Human G-protein chemokine receptor (CCR5) HDGNR10 |
EP1723178A4 (de) | 2004-03-12 | 2007-12-12 | Human Genome Sciences Inc | Humaner g-protein-chemokinrezeptor (ccr5) hdgnr10 |
WO2005106492A2 (en) * | 2004-04-30 | 2005-11-10 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with c-c chemokine receptor 3 (ccr3) |
ES2450929T3 (es) | 2004-10-29 | 2014-03-25 | Topigen Pharmaceuticals Inc. | Oligonucleótidos antisentido para tratar la alergia y la proliferación de las células neoplásicas |
US8008092B2 (en) * | 2007-10-09 | 2011-08-30 | University Of Kentucky Research Foundation | CCR3 inhibition for ocular angiogenesis and macular degeneration |
WO2010138591A1 (en) | 2009-05-26 | 2010-12-02 | University Of Kentucky Research Foundation | Ccr3 and its ligands are therapeutic and diagnostic targets for neovascular age-related macular degeneration |
ES2764840T3 (es) | 2015-01-28 | 2020-06-04 | Univ Bordeaux | Uso de plerixafor para tratar y/o prevenir exacerbaciones agudas de la enfermedad pulmonar obstructiva crónica |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5225538A (en) * | 1989-02-23 | 1993-07-06 | Genentech, Inc. | Lymphocyte homing receptor/immunoglobulin fusion proteins |
US5284746A (en) | 1990-02-08 | 1994-02-08 | Zymogenetics, Inc. | Methods of producing hybrid G protein-coupled receptors |
US5462856A (en) | 1990-07-19 | 1995-10-31 | Bunsen Rush Laboratories, Inc. | Methods for identifying chemicals that act as agonists or antagonists for receptors and other proteins involved in signal transduction via pathways that utilize G-proteins |
US5453491A (en) | 1990-09-11 | 1995-09-26 | Kiyoshi Takatsu | Murine interleukin-5 receptor |
US5543503A (en) | 1991-03-29 | 1996-08-06 | Genentech Inc. | Antibodies to human IL-8 type A receptor |
US5668006A (en) | 1992-07-17 | 1997-09-16 | American Cyanamid Company | Somatostatin receptors |
AU4855393A (en) | 1992-09-10 | 1994-03-29 | New York University | Polypeptides of g-coupled receptor proteins, and compositions and methods thereof |
JP3664176B2 (ja) | 1992-11-10 | 2005-06-22 | ジェネンテック・インコーポレーテッド | C−c ckr−1,c−cケモカインレセプター |
EP0846762A3 (de) | 1992-11-17 | 1998-09-23 | Icos Corporation | Neue Sieben-Transmembran-Rezeptor V31 |
US5652133A (en) | 1993-01-28 | 1997-07-29 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Cloning and expression of the human macrophage inflammatory protein-1.alpha.α) /rantes receptor |
US5514555A (en) | 1993-03-12 | 1996-05-07 | Center For Blood Research, Inc. | Assays and therapeutic methods based on lymphocyte chemoattractants |
DE4332256C1 (de) | 1993-09-22 | 1995-03-09 | Lipp Martin Dr Dr Habil | Monoklonale Antikörper gegen Leukozyten-spezifische G-Protein-gekoppelte Rezeptoren |
US6806061B1 (en) * | 1995-01-19 | 2004-10-19 | Children's Medical Center Corporation | G protein-coupled receptor gene and methods of use therefor |
US6512103B1 (en) | 1995-12-08 | 2003-01-28 | Schering Corporation | Mammalian chemokine reagents |
US6265184B1 (en) | 1995-12-20 | 2001-07-24 | Icos Corporation | Polynucleotides encoding chemokine receptor 88C |
-
1995
- 1995-01-19 US US08/375,199 patent/US6806061B1/en not_active Expired - Fee Related
-
1996
- 1996-01-19 JP JP8522363A patent/JPH10512753A/ja not_active Ceased
- 1996-01-19 AT AT96907010T patent/ATE426024T1/de not_active IP Right Cessation
- 1996-01-19 DE DE69637874T patent/DE69637874D1/de not_active Expired - Lifetime
- 1996-01-19 EP EP96907010A patent/EP0828828B1/de not_active Revoked
- 1996-01-19 AU AU50202/96A patent/AU688206B2/en not_active Ceased
- 1996-01-19 ES ES96907010T patent/ES2324502T3/es not_active Expired - Lifetime
- 1996-01-19 CA CA002207086A patent/CA2207086A1/en not_active Abandoned
- 1996-01-19 WO PCT/US1996/000608 patent/WO1996022371A2/en not_active Application Discontinuation
-
1997
- 1997-07-18 KR KR19970704962A patent/KR19980701570A/ko not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
ES2324502T3 (es) | 2009-08-07 |
AU688206B2 (en) | 1998-03-05 |
WO1996022371A3 (en) | 1996-10-17 |
CA2207086A1 (en) | 1996-07-25 |
EP0828828B1 (de) | 2009-03-18 |
JPH10512753A (ja) | 1998-12-08 |
KR19980701570A (de) | 1998-05-15 |
AU5020296A (en) | 1996-08-07 |
ATE426024T1 (de) | 2009-04-15 |
US6806061B1 (en) | 2004-10-19 |
WO1996022371A2 (en) | 1996-07-25 |
EP0828828A2 (de) | 1998-03-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69637874D1 (de) | C-C CHEMOKIN REZEPTOR 3: CKR-3 ODER Eos-L2 | |
LU90591I2 (fr) | Enbrel-etanercept | |
ATE182901T1 (de) | Für androgen-rezeptor-protein kodierende dna | |
NO961115D0 (no) | Humane metabotrope glutamatreseptorsubtyper (HMR4, HMR6, HMR7) og relaterte DNA forbindelser | |
ES2147553T3 (es) | Vectores virales recombinantes para la expresion en unas celulas musculares. | |
BR9813608A (pt) | Polipeptìdeo isolado, sequências de ácido nucleico isolado e mutante, construção de ácido nucleico, vetor de expressão recombinante, célula hospedeira recombinante, processos para produzir uma sequência de ácido nucleico mutante, para produzir um polipeptìdeo, para produzir um mutante de uma célula originária e para produzir uma proteìna, e, célula mutante | |
EP1464706A3 (de) | HEK5, HEK7, HEK8, HEK11, EPH-ähnliche Protein-Tyrosinkinase-Rezeptoren | |
PT93910A (pt) | Prodesso para a preparacao de uma proteina heterologa mediante secrecao a partir de uma celula | |
DE69738514D1 (de) | Verbesserte expressionsvektoren | |
ATE352626T1 (de) | Polypeptide mit galaktoseoxidaseaktivität und dafür kodierende nukleisäuren | |
ATE414775T1 (de) | Polypeptide mit prolyldipeptidylaminopeptidase- aktivität und dafür kodierende nukleinsäuren | |
WO1995009872B1 (en) | Dna encoding prostaglandin receptor ip | |
DE69837475D1 (de) | Polypeptide mit aminopeptidaseaktivität und dafür kodierende nukleinsäuren | |
AR016436A1 (es) | Proteina que inhibe a la p27, adn que la codifica, anticuerpos y productos de disociacion de los mismos, acido nucleico antisentido, estructura artificialde acido nucleico y la utilizacion de todo esto en terapia y profilaxis de enfermedades | |
KR940021579A (ko) | 골(骨)-관련 전사 조절인자형 단백질 및 이의 제조방법 | |
AUPN154295A0 (en) | Nucleic acid molecule encoding a protein with avian gamma-interferon activity | |
CA2032167A1 (en) | Dna coding for protein binds to enhancer of.alpha.-fetoprotein gene | |
ATE302214T1 (de) | Enamel-matrix bezogene polypeptide | |
EP0811685A3 (de) | Menschliche Rezeptoren für den von Blutplättchen abstammenden Wachstumsfaktor | |
DE69634757D1 (de) | Vektor zur expression von n-terminal verlängerten proteinen in hefezellen | |
WO1999063094A3 (en) | Nucleotide and protein sequences of gpr1 and methods based thereon | |
DK595187A (da) | Minactivin og fremgangsmaade til fremstilling deraf | |
WO1997008317A3 (en) | Human hypothalmic ('hr') receptor polypeptide compositions, methods and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8363 | Opposition against the patent |